// App-Quantinova.ai

6533 : Impact of donor source on allogeneic stem cell transplantation for Philadelphia chromosome-negative acute lymphoblastic leukemia.

Researchers

Presenter

  • Satoshi Nishiwaki

Principal Investigators

  • Koichi Miyamura

  • Kazuteru Ohashi

  • Junji Tanaka

  • Mineo Kurokawa

  • Shuichi Taniguchi

  • Takahiro Fukuda

  • Kazuhiro Ikegame

  • Hisashi Sakamaki

  • Yasuo Morishima

  • Koji Kato

  • Ritsuro Suzuki

Medical Centers

  • Department of Pathologic Oncology, Mie University Graduate School of Medicine, Mie, Japan

  • Department of HSCT Data Management/Biostatistics, Nagoya University Graduate School of Medicine, Nagoya, Japan

  • Department of Pediatrics, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan

  • Department of Hematology, Toranomon Hospital, Tokyo, Japan

  • Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital, Tokyo, Japan

  • Department of Radiology, Okayama University Graduate School of Medicine, Okayama, Japan

  • Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan

  • Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan

  • Department of Stem Cell Transplantation, National Cancer Center, Tokyo, Japan

  • Department of Pediatrics, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan

  • Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Allopurinol

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A